ANA
LLUCH HERNANDEZ
EMÉRITO/A UNIVERSIDAD
Centro de Investigación Biomédica en Red de Cáncer
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Centro de Investigación Biomédica en Red de Cáncer (19)
2024
-
MiRNA-449 family is epigenetically repressed and sensitizes to doxorubicin through ACSL4 downregulation in triple-negative breast cancer
Cell Death Discovery, Vol. 10, Núm. 1
2023
-
Author Correction: Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer (npj Breast Cancer, (2021), 7, 1, (1), 10.1038/s41523-020-00208-2)
npj Breast Cancer
-
Clinical Impact of New Treatment Strategies for HER2-Positive Metastatic Breast Cancer Patients with Resistance to Classical Anti-HER Therapies
Cancers, Vol. 15, Núm. 18
-
Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy
ACS Applied Materials and Interfaces, Vol. 15, Núm. 32, pp. 38323-38334
-
Development of a Novel NGS Methodology for Ultrasensitive Circulating Tumor DNA Detection as a Tool for Early-Stage Breast Cancer Diagnosis
International Journal of Molecular Sciences, Vol. 24, Núm. 1
-
Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and mitochondrial damage in cancer cells
Cell Death and Differentiation, Vol. 30, Núm. 5, pp. 1366-1381
-
High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer
International journal of molecular sciences, Vol. 24, Núm. 4
-
Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 29, Núm. 2, pp. 389-400
-
miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer
Cancers, Vol. 15, Núm. 7
2022
-
Role of germline variants in the metastasis of breast carcinomas
Oncotarget, Vol. 13, Núm. 1, pp. 843-862
-
The value of sentinel lymph-node biopsy after neoadjuvant therapy: an overview
Clinical and Translational Oncology, Vol. 24, Núm. 9, pp. 1744-1754
-
miR-99a-5p modulates doxorubicin resistance via the COX-2/ABCG2 axis in triple-negative breast cancer: from the discovery to in vivo studies
Cancer Communications
2021
2020
-
Circulating mir-99a-5p expression in plasma: A potential biomarker for early diagnosis of breast cancer
International Journal of Molecular Sciences, Vol. 21, Núm. 19, pp. 1-14
2019
-
A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients
Clinical Epigenetics, Vol. 11, Núm. 1
-
Detection of TP53 and PIK3CA mutations in circulating tumor DNA using next-generation sequencing in the screening process for early breast cancer diagnosis
Journal of Clinical Medicine, Vol. 8, Núm. 8
2018
-
MSK1 regulates luminal cell differentiation and metastatic dormancy in ER + breast cancer
Nature Cell Biology, Vol. 20, Núm. 2, pp. 211-221
-
Erratum to: MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+ breast cancer (Nature Cell Biology, (2018), 20, 2, (211-221), 10.1038/s41556-017-0021-z)
Nature Cell Biology